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Abstract 
Proteins are only moderately stable. It has long been debated whether this narrow range of 
stabilities is solely a result of neutral drift towards lower stability or purifying selection against 
excess stability is also at work — for which no experimental evidence was found so far. Here we 
show that mutations outside the active site in the essential E. coli enzyme adenylate kinase result 
in stability-dependent increase in substrate inhibition by AMP, thereby impairing overall enzyme 
activity at high stability. Such inhibition caused substantial fitness defects not only in the 
presence of excess substrate but also under physiological conditions. In the latter case, substrate 
inhibition caused differential accumulation of AMP in the stationary phase for the inhibition 
prone mutants. Further, we show that changes in flux through Adk could accurately describe the 
variation in fitness effects. Taken together, these data suggest that selection against substrate 
inhibition and hence excess stability may have resulted in a narrow range of optimal stability 
observed for modern proteins. 
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Introduction 
Most proteins (except IDPs) must be sufficiently stable to fold to a native 3D structure, resist 
thermal fluctuations and proteolytic degradation in the cell and carry out function. Hence 
selection for protein folding stability must have been an important parameter during evolution. 
Naïvely this suggests that proteins would continuously evolve towards higher thermostability. In 
reality, however, this is not the case, and in fact most natural proteins are only moderately stable, 
with foldingG'  in the range of −5 to −10 kcal/mol (1-3). Origins of such a narrow range of 
stabilities has intrigued researchers for long. Theoretical approaches which addressed this issue 
have employed evolutionary simulations, where studies have shown that on a protein folding 
driven thermodynamic fitness landscape, selection for folding stability need not result in highly 
stable proteins (3-5). In the regime of unstable proteins, selection for folding stability would lead 
to fixation of predominantly stabilizing mutations. On the other hand, in the regime of stable 
proteins, both stabilizing as well as destabilizing mutations have a very low selection coefficient, 
and hence have a low probability of fixation. However, since the supply of mutations is largely 
destabilizing, this results in more destabilizing mutations being fixed in the population (4-8). At 
some intermediate value of folding stability, mutation-selection balance happens, where 
stabilizing and destabilizing mutations have equal probability of getting fixed, thereby giving 
rise to the observation that proteins are marginally stable. 
A contrary hypothesis has also been provided which states that marginal stability is the result of 
a fitness penalty at very high protein stability (9, 10). In other words, there is an optimal stability 
of proteins, beyond which on both sides fitness drops. It was hypothesized that drop in fitness at 
high stability is due to loss of protein flexibility that is important for its activity, resistance to 
proteolytic degradation, etc. At the heart of this fitness penalty, lies the concept of stability-
activity tradeoff (11). Indeed, directed evolution experiments that aim to improve protein 
stability with no constraint on its function often lead to mutations in the active site and 
subsequent loss in activity (12). Moreover, specific substitutions in the active site of a protein 
often lead to stabilization with loss of activity (11, 13-15). This observation can be partly 
attributed to the fact that most substitutions in a protein are deleterious (16, 17). However, such 
trade-off can also be real as nature had to compromise protein stability while carving out an 
active site on a stable 3D scaffold, and active sites often have unfavorable conformations like 
4 
 
buried polar amino acids or like-charges proximal to each other, etc. However, for substitutions 
outside the active site, such trade-off has not been demonstrated convincingly. Instead a positive 
correlation between stability and activity was found in one case (15). Thermophilic counterparts 
of mesophilic enzymes present an interesting case to explore stability-activity trade-off, however 
such studies have also yielded contradictory results. HD exchange experiments showed that 
thermophilic 3-isopropylmalate dehydrogenase was significantly more rigid at room temperature 
than the E. coli enzyme, with concomitant loss in activity (18). On the contrary, Nyugen et al 
successfully reconstructed a thermophilic ancestral adenylate kinase that was both thermostable 
as well as had comparable activity as the mesophilic enzyme at lower temperature (19). 
To address whether high stability impairs activity with possible consequences for bacterial 
fitness, we used adenylate kinase (Adk) as a model protein. Adk is a reversible enzyme that 
inter-converts among adenylate currencies (ATP, ADP and AMP), and is essential in all forms of 
life. It undergoes large conformational fluctuations during catalysis (20-22), and therefore the 
effect of global protein stability on its activity is particularly interesting. In a previous study, we 
found that destabilizing mutations in Adk preferentially modulate E. coli lag times through 
changes in Adk catalytic capacity abundance´ k
cat
K
M( ) (23). In this study, we introduced 
stabilizing mutations in Adk outside its active site. We found a positive correlation between the 
conventional activity parameter k
cat
K
M
 and stability, implying no trade-off, as was posited in 
other studies. Interestingly, we uncover a positive correlation between stability and substrate 
inhibition by AMP. This molecular-level effect has strong implications for physiology of E. coli. 
When placed on the genome, such stabilized variants of Adk exhibit extended lag times during 
growth. Furthermore, in the presence of external AMP, extension of lag times became much 
more pronounced along with significant drop in growth rates, which could be captured 
effectively using all the measurable biophysical and cellular properties of the enzyme. Our study 
therefore reveals a hitherto unexplored aspect of a protein’s activity, substrate inhibition, that is 
substantially modulated by its global stability, and can potentially explain the observed moderate 
stability of mesophilic Adks. 
Results 
Stable mutants of Adk show increased substrate inhibition by AMP 
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We engineered several stabilizing mutations at 8 different locations in E. coli Adk (Fig 1A, 
Table 1) based on two different approaches: first, using a consensus approach, where we 
substituted the E. coli amino acid with the most conserved amino acid at that location based on a 
multiple sequence alignment (see Methods); second, replacing by an amino acid that has been 
shown to stabilize Adk from Bacillus subtilis (24, 25) (see Methods) at equivalent position on the 
structure. The mutations chosen by the consensus approach were far away from the active site, 
i.e., they were at least 8 Å away from Ap5A, an inhibitor of Adk (PDB:1ake (26)). The 
mutations identified using the above two approaches were single-site mutants with 'T
m
 in the 
range of 1-6 qC. Further, we combined mutations if their Cα-Cα distance on the structure were 
≥10 Å (see Methods). Overall, the range of stability gains obtained for the single-site as well as 
multi-site mutants was 1-9 qC above WT Adk in terms of T
m
. We measured the activity of Adk 
in the direction of ADP formation: ATP + AMP® 2ADP . We used saturating concentration of 
ATP and varied concentration of AMP in reactions. The initial velocity vs AMP concentration 
plot for Adk deviates from the conventional Michaelis-Menten kinetics (Fig 1B). The rate of 
reaction decreases at high AMP concentration, exhibiting substrate inhibition. Indeed, such 
inhibition of Adk by AMP has been reported previously (27, 28). We used the following model 
of uncompetitive inhibition to quantify the effect of substrate inhibition: 
 v
0
=
k
cat
E
0
éë ùû AMPéë ùû
K
M
+ AMPéë ùû 1+
AMPéë ùû
K
I
æ
èç
ö
ø÷
  (1) 
where 0v  is the initial rate of ADP formation, > @0E  and > @AMP  are the concentrations of Adk 
and AMP, respectively, used in the reaction, catk  is the turnover rate of Adk, whereas MK  and 
K
I
 are the affinity- and inhibition-constants related to AMP, respectively. The K
I
 of WT Adk 
at 25qC was 930 PM. Interestingly, for most of the stabilized Adk mutants, inhibition was much 
stronger than WT ( )lower IK  (representative plots for WT (blue) and a stable mutant (red) are 
shown in Fig 1B). To find out if substrate inhibition was related to stability of the Adk proteins, 
we selected a set of destabilized mutants from our previous study (23) (Table 1). Remarkably, 
substrate inhibition was almost completely abolished for most of the destabilized mutants (e.g. 
green line in Fig 1B shows the kinetic curve for destabilized mutant V106W). For a wide range 
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of T
m
 on either side of WT, K
I
 values showed a strong dependence on stability T
m( )  of the 
proteins (Fig 1C, r = −0.67, p = 1.1e−3), with higher stability resulting in stronger substrate 
inhibition. 
However, we note that mutant L82V showed strong inhibition, even though it was only 
marginally more stable than WT 'T
m
= 0.6 qC( ). In fact, it showed the strongest inhibition 
among all mutants considered in this study. This suggests that in addition to changes in stability, 
K
I
 may be modulated by position specific effects, presumably through allostery. With the 
exclusion of L82V, the correlation between stability and substrate inhibition is much stronger 
(r = −0.80, p = 3.3e−5). 
Variation of enzymatic activity with stability 
Previous studies that sampled mutations outside the active-site found no trade-off between 
activity and stability of the protein (15, 29). However, in case of mutant Adk proteins that span 
~20qC range of stability, we observed that while most destabilized proteins had catk  values close 
to WT levels, several of the stabilized mutants show a slight drop in k
cat
, thereby resulting in an 
overall weak negative correlation with stability (Fig S1A, r = −0.46, p = 1.8e−2). We excluded 
all mutations that involve 16th position from all correlations reported in this section as Q16 is 
very close to the active site residues (CD distance to the closest active site residue is <4 Å) 
(Fig 1A). Contrary to k
cat
, affinity towards AMP ( )MK  improves significantly with stability 
(Fig S1B, r = −0.71, p = 5.2e−5), which in turn drives the positive correlation between stability 
and k
cat
K
M
. In other words, the enzyme becomes more efficient as it becomes more stable and 
this implies no trade-off between activity and stability for mutations away from active site 
(Fig 2A, r = 0.68, p = 1.3e−4). Similar positive correlation was reported for another enzyme, 
DHFR, in a previous study (15). 
Interestingly, we also found that strong affinity ( )MK  of Adk towards AMP also results in 
strong inhibition by AMP ( )IK  (Fig 2B, r = 0.66, p = 1.6e−3). At the same time, enzyme 
efficiency ( )cat Mk K  and substrate inhibition ( )IK  trade off (Fig 2C, r = −0.65, p = 2.8e−3). 
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Such trade-off is a significant effect as it implies that efficiency of stabilized forms of Adk is 
limited due to inhibition. 
Mutant Q16F was the most stabilizing single site mutant in our study 'T
m
= 6.5 qC( ) . It was 
selected based on a previous laboratory evolution experiment in Bacillus subtilis (24). However, 
this mutant and all combination mutants containing Q16F had very low activity as Q16 is very 
close to the active site (Fig 1A, red sphere and Fig 2A, red circles). These mutants therefore 
represent a classic case of activity-stability tradeoff at the active site. Interestingly these mutants 
did not show any detectable substrate inhibition in the concentration range of AMP studied 
(Table 1). This represents a case where extreme loss in activity leads to complete abolition of 
inhibition, and therefore is in line with our observation that k
cat
K
M
 and K
I
 trade-off. 
Flux through Adk explains drop in fitness 
Our biophysical studies demonstrated that stabilizing mutants exhibit strong AMP-dependent 
substrate inhibition. We therefore hypothesized that the inhibitory effects of AMP on the 
essential enzyme Adk could result in fitness defects when grown in the presence of large excess 
of external AMP. To that end, we engineered a selected subset of stabilized and destabilized Adk 
variants on the genomic copy in E. coli and measured fitness effects (growth rate and lag time of 
engineered strains) as well as intracellular abundance of the mutant Adks (Table S1) in the 
presence and absence of AMP. To find out the dynamic range of AMP concentrations in which 
the largest change in fitness effects are seen, we first measured growth curves of WT and the 
most inhibited mutant in this study, L82V, in a minimal media (M9) and a 0-10 mM range of 
external AMP concentrations. Indeed, we found that the lag time increased, for both WT and 
L82V, with addition of excess AMP up to ~400 PM, beyond which there was no substantial 
change (Fig S2). Subsequently we carried out growth experiments with all Adk variants in 0-
400 PM range of AMP. Remarkably, only stabilized mutants which exhibit strong substrate 
inhibition (low K
I
 values) showed an AMP-dependent drop in growth rate and increase in lag 
times, whereas the uninhibited mutants exhibited little-or-no effect (Fig 3A,B,C). This also 
shows that there is no generic toxicity due to additional AMP – the effect stems from inhibition 
of Adk by additional AMP in WT and some mutants. We utilized flux-dynamics theory (30) to 
relate the changes in fitness to changes in flux through Adk when excess AMP is present. The 
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theory has been successfully used previously to explain fitness dependence on the activity of E-
galactosidase (31), DHFR (32-34), and Adk (23). In the present case, we model the fitness 
dependence as follows: 
 fitness, =
+
V
F a
b V
  (2) 
where, V is the flux through Adk, a  is the maximum fitness when the flux is maximum, and b  
is a constant representing background effect from all other enzymes. The flux through Adk is 
modeled as the rate at which AMP is converted to ADP and is related to equation (1) as follows: 
 
> @
> @ > @1
cat
M
I
k AMP
V Abundance
AMP
K AMP
K
= ´
æ ö+ +ç ÷
è ø
  (3) 
Using measured intracellular abundances and biophysical properties of Adk variants 
( ), ,cat M Ik K K , we calculated V  for WT and mutants at zero external AMP 0( )V  and under 
different concentrations of external AMP ( )AMPV . For all 0( )V  calculations, we assumed 
intracellular AMP concentration to be 280 PM (35), while for ( )AMPV , it was > @280+ AMP  PM. 
Since change in fitness is the largest for inhibition-prone mutants which in turn have low flux 
due to strong IK  values as per Eq (3), we can assume that for such mutants V b . In such a 
regime, Eq (2) simplifies to the following form: 
 fitness, 
V
F a
b
|  
In the opposite regime of high flux through Adk when V bt  fitness becomes weakly dependent 
on V 
 , 1
æ ö| ç ÷è ø
b
fitness F a
V
 
which further implies that the change in fitness upon addition of AMP 
( ) ( )0 0AMP AMPF F F V V' =  v   when V b , and approximately plateaus with 0AMPV V  when 
V bt . Hence, we projected fitness components (change in growth rate and lag times) on 
( )0AMPV V  (Fig 3D,E), and found that the change in flux upon AMP addition is well described 
by Eq (2) and it correlated with fitness changes very significantly with Spearman 
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0.65,  1.5 9p eU = =   for growth rate and 0.78,  3.0 15p eU =  =   for lag time, respectively 
(Fig 3D,E). For mutants which show strong AMP dependent inhibition (shown in circles in 
Fig 3D,E), addition of AMP causes a drop in flux which is reflected in concomitant drop in 
fitness (decreased growth rates or increased lag times). On the other hand, mutants that lack 
inhibition (represented as triangles in Fig 3D,E) show an increase in flux with additional AMP. 
Consistent with the flux-dynamics theory Eq (2) predicts the law of diminishing returns (30, 31, 
33), increase in flux beyond its native levels do not change fitness for these mutants. The mutants 
that do not show substrate inhibition therefore remain on the fitness plateau. 
Additional AMP leads to accumulation of adenylate metabolites in the exponential phase 
Adk is an essential enzyme that interconverts adenylate currencies in the cell. It was interesting 
therefore to find out what happens to levels of ATP, ADP and AMP in mutant strains and under 
conditions of AMP inhibition. To that end, we measured intracellular levels of relevant 
metabolites of a selected set of mutants in the absence and in the presence of high concentrations 
of external AMP during exponential phase of growth. In the absence of external AMP, levels of 
three adenylate metabolites in mutant strains did not differ significantly from WT (Fig 4). 
However, in the presence of 400 PM AMP in growth media, mutants L107I+V169E and L82V, 
which show strong substrate inhibition, accumulated extremely high levels of all three 
metabolites ATP, ADP and AMP. In contrast, destabilized mutant V106W and WT did not 
accumulate these metabolites even at high AMP concentration. Presumably, in the presence of 
high AMP concentration, the majority of the mutant Adks that have low K
I
 remain in inhibited 
(bound) form, thereby not allowing the enzyme to carry out reaction in any direction and leading 
to accumulation of all three substrates. Previous studies have shown that accumulated AMP in 
yeast is often converted to IMP to prevent the slowdown of growth (36). In our study too, we 
observe accumulation of IMP in all four strains. The buildup is higher for L107I+V169E and 
L082V, as they accumulate more AMP due to inhibition. 
Physiological effect of substrate inhibition 
The data presented so far establishes conclusively that the increase in stability results in higher 
substrate inhibition in Adk. Such inhibition is also reflected in loss of fitness given appropriate 
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conditions of excess substrate and therefore those ‘selected’ conditions can potentially limit the 
stability range of the protein. However, can substrate inhibition be realized under physiological 
conditions? This is an important evolutionary question, because if true, then there is a fitness cost 
due to increased stability. Brauer et. al. (37) showed that sudden and severe limitation of carbon 
source resulted in accumulation of AMP in E. coli. Based on this finding, we presumed that 
AMP might accumulate during the stationary phase too, as during this time carbon and other 
energy resources deplete. In such a scenario, when cells resume a new cycle of growth upon 
resource availability, the mutants with substrate inhibition will result in extended lag and 
subsequent fitness loss. To that end, we carried out metabolomics analysis of WT and L82V 
mutant strains during different phases of growth. Surprisingly, however, we found that all 
adenylate metabolites, including AMP drastically drop in the stationary phase as compared to the 
exponential phase (Fig 5A). The observed difference between these two experiments might arise 
because Brauer et.al. deprived the cells of carbon source in the exponential phase, while in our 
experiments all resources, including carbon, gradually decrease as a function of growth. In our 
study, the AMP levels in stationary phase drop to ~25% of that in exponential phase, ADP to 
~15%, and ATP to almost 10% in WT. The overall pattern of drop in metabolites remains similar 
in L82V, the most inhibited mutant in this study. However, on a closer look, we found that 
relative to WT, mutant L82V contained more of all three adenylate metabolites (Fig 5B) in 
stationary phase, as opposed to during exponential phase where they were not substantially 
different (Fig 4 and Fig 5A). Specifically, AMP levels were ~1.38 times higher in L82V 
compared to WT. So, can higher levels of AMP in mutants relative to WT during stationary 
phase explain the variation in lag times at zero external AMP? To address this question, we 
calculated change in flux between mutant and WT Adk ( )mut WTV V  using equation (3) in the 
following way: assuming AMP concentration during exponential phase of E. coli growth to be 
280 PM (35), and AMP levels in stationary phase to be 25% of exponential levels (this study, Fig 
5A), we consider > @WTAMP  to be 70 PM for flux calculations. Next, we assumed all mutants to 
have same levels of AMP > @( )mutAMP  in stationary phase and it was set to 96 PM as per our 
metabolomics data for L82V (1.38 fold of WT levels). With these values, ( )mut WTV V  showed a 
significant correlation (Spearman 0.54,  2.8 2p eU =  =  ) with observed change in lag times of 
mutants in the absence of any additional AMP in the medium (Fig 5C). 
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To gain further insight into the regimes of intracellular AMP concentrations in mutants and WT 
that may lead to significant correlation between flux and lag times, we modeled intracellular 
AMP concentration for WT in stationary phase to vary from 25 PM to 100 PM, which are ~10-
35% of AMP during the exponential phase (280 PM). For each concentration of > @WTAMP , we 
also assumed the ratio of > @ > @mut WTAMP AMP  to vary from 0.4 to 4.0. For each pair of > @WTAMP  
and > @mutAMP , we calculated the Spearman correlation coefficient between ( )mut WTV V  and 
experimentally observed change in lag times of mutants (at 0 external AMP) as in Fig 5C. 
Interestingly, we find that the correlation is significant only if mutants have higher AMP levels 
than WT during the stationary phase (Fig 5D). 
Overall, these results show that even under physiological conditions substrate inhibition is 
essential for mutant Adk activity and it can cause loss of fitness for such mutants. This in turn 
can act as an evolutionary constraint that limits excessive protein stability for adk. 
Discussion 
The physical or evolutionary reasons behind relatively low stability of modern-day mesophilic 
proteins have been at the center of a long-standing debate. Theoretical studies explain this based 
on the large supply of destabilizing mutations. A competing hypothesis suggests fitness penalty 
at high stability, however no experimental evidence exists till date. Here, we engineered 
stabilized mutants of an essential E. coli enzyme Adenylate Kinase and show that though such 
mutants have improved catalytic efficiency in terms of k
cat
K
M
, they also exhibit strong 
substrate inhibition by AMP. AMP substrate inhibition is a well-known phenomenon for E. coli 
Adk (27, 28), here we uncover that this property of the enzyme is modulated by stability. 
Remarkably, destabilized mutants of Adk are also significantly less inhibited by AMP, to an 
extent that it is completely abolished for some mutants. We also show that the substrate 
inhibition constant K
I
 shows a trade-off with enzyme efficiency k
cat
K
M
. This observation 
implies that while improving stability that lead to more efficient Adks, the net velocity given by 
equation (1) will always be limited by substrate inhibition in the regime of high substrate 
concentrations. 
We also show that substrate inhibition can result in pronounced fitness effects. In the presence of 
excess AMP, we show that the observed fitness effects can be accurately described using flux 
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dynamics theory and a biophysical fitness function. More interestingly, variations in fitness 
effects were also observed under physiological conditions in the absence of any additional AMP. 
Using metabolomics data, we were able to explain this variation based on differential levels of 
AMP in the stationary phase for inhibition-prone mutants. This result has important implications 
in terms of evolution of protein stability. Due to absence of any evidence of fitness penalty at 
high stability, it was always believed that the fitness landscape is monotonic with respect to 
protein stability: reduced fitness at low stability due to low folded fraction, and essentially 
reaching a plateau once the fraction unfolded becomes negligible. Our results show that this 
landscape can be non-monotonic for some proteins, where high stability can impair activity 
through substrate inhibition. Our findings can be depicted in a schematic fitness landscape as 
shown in Fig 6, where a bell-shaped fitness landscape along stability axis arises due to substrate 
inhibition at high stability and it may indicate origins of moderate stabilities in Adk. Since 
substrate inhibition is a reality for ~20-30% of natural enzymes (38, 39), the observed 
phenomenon of increased inhibition upon stabilization might be applicable to these enzymes as 
well. 
Of course, the fitness penalty at high stability and the relief of substrate inhibition upon 
destabilization does not suggest that large destabilization is beneficial for the enzyme. 
Destabilization concomitantly worsens MK , and reduces intracellular abundance of the enzyme 
through greater contribution of degradation in turnover (32), as seen here and also in our 
previous study (23). Together this causes reduced flux through the enzyme and ultimately results 
in increase in lag times and lower fitness, even in the absence of AMP inhibition. 
An interesting observation from our study is that IK  of WT (~900 PM) is much higher than 
intracellular AMP concentration (280 PM), which implies that substrate inhibition is effectively 
not realized for WT under physiological conditions. On the contrary, for several stabilizing 
mutants the IK  values are in the range of 200-300 PM (Table 1). Since intracellular metabolite 
concentrations are generally tightly regulated (40), a reasonable evolutionary strategy would be 
to evolve Adk stabilities in a range where inhibition effects are minimal. 
We found that higher stability also leads to tighter binding to AMP K
M( ) and lower catk . 
Though the mechanism behind this is unclear, it is possible that stabilizing mutants stabilize the 
ligand bound closed-state of Adk more than the unbound open state (Fig S3), and hence increase 
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the free energy of binding to the ligand (improved DK , hence improved MK ). However, such 
effect might also decrease catk  by increasing the activation barrier between the ligand-bound 
closed state and the transition state of the phosphate transfer reaction. The stabilization may also 
result in lower interconversion rate between open and closed states in stable mutants. This is in 
agreement with recent single-molecule FRET study in Adk where mutations that reduced the rate 
of interconversion also reduced the k
cat
 (41). 
Of course, the big question remains unanswered: why does higher stability cause stronger 
inhibition? At the heart of this, lies the mechanism of AMP substrate inhibition of Adk, which 
has been an area of long-standing research. The general mechanism of substrate inhibition is 
assumed to be uncompetitive where AMP binds at an independent allosteric site (27). An 
alternative mechanism is that binding of AMP to its own site causes closure of the ATP binding 
pocket, leading to inhibition (28). A third mechanism is that inhibition is due to AMP binding 
competitively at the ATP-binding site (42). Though elucidation of the exact mechanism is 
beyond the scope of this work, this knowledge will be crucial to understand how stability 
modulates inhibition. We like to note in passing that in our attempt to get a mechanistic insight, 
we measured binding affinities of WT Adk, mutants M21A+L107I and L82V to the inhibitor 
Ap5A, which binds to both AMP and ATP binding site simultaneously (43). In accordance with 
the trends in IK values, DK  for Ap5A were in the order of L82V< M21A+L107I <WT, implying 
that mutants that bind Ap5A strongly are also the ones that show strong AMP inhibition 
(Fig S4). This might hint at the third mechanism, in which stabilization of Adk somehow 
improves affinity of AMP at the ATP binding site, however further experiments are required to 
completely understand the mechanism. 
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Methods 
Selection of mutations: We attempted to design stable mutant of Adk with as few substitutions as 
possible. It is known that consensus mutations can increase the protein stability (44-48). Hence, 
we built a dataset of 895 adk protein sequences collated from ExPASy Enzymes (49) (as of Nov. 
2012), clustered them at 99% sequence identity using CD-HIT (50), aligned and counted 
frequency of each amino acid and gaps at every position. Consensus amino acid at a position is 
the one with the highest frequency. In E. coli Adk, 56 positions were found to be out of 
consensus. Further pruning was done based on following criteria: a residue whose side chain is 
not involved in any hydrogen bonding and is at least 8Å away from bound inhibitor Ap5A based 
on pdb 1ake (26). Structure of E. coli Adk can be divided into three domains: LID (residues 118-
160), NMP (residues 30-67), and Core (residues 1-29, 68-117, and 161-214). There are 28 
residues which satisfy abovementioned criteria, of which 20 are in the Core domain, 5 in the 
LID, and 3 in the NMP. We randomly chose 6 positions from Core domain and constructed 
individual back-to-consensus mutations: M21A, M96L, L107I, V169E, L209I, and E210L. We 
define the active-site as the residues whose accessible surface area changes by more than 5 Å2 in 
the presence of the inhibitor Ap5A. A similar criterion was used to define the residues contacting 
the active site. All the 6 selected positions were not only away from the inhibitor, but also not in 
direct contact with any active site residues.  
Q16L and T179M were previously found to be stabilizing in Adk of Bacillus subtilis (24, 25). 
Based on that, we constructed Q16F, Q16Y, and T175M in E. coli Adk at structurally equivalent 
positions to Bacillus Adk. Such positions were determined by aligning structures of Adk from 
E. coli (pdb: 1ake) and B. subtilis (pdb: 1p3j (51)) using MUSTANG (52). 
Additionally, we combined individually-stabilizing mutations to make 2- or 3-site mutants if 
their CD atoms are at least 10 Å far apart from each other. 
For destabilizing candidates, we chose several mutants from our previous study (23). 
Mutagenesis and protein purification: We cloned adk gene in pET28a(+) vector between NdeI 
and XhoI restriction sites. The mutagenesis was carried out by amplifying the whole plasmid 
using inverse PCR protocol, KOD hot-start DNA polymerase, and a pair of partially 
complementary mutagenic primers (30-35 bp long). Such amplified plasmids were transformed 
in E. coli DH5D competent cells for faithful propagation and storage. For protein purification, 
pET28a(+) plasmids with WT and mutant adk were transformed in E. coli BL21(DE3), grown in 
15 
 
1 liter terrific broth and induced with 1 mM IPTG at OD600 of 0.6. The proteins were purified 
using Ni-NTA affinity columns (Qiagen) and subsequently passed through a HiLoad Superdex 
75 pg column (GE). The proteins eluted as a monomer. The corresponding fractions were pooled 
together, concentrated and dialysed against 10 mM potassium phosphate buffer (pH 7.2). The 
concentration of the proteins was measured by BCA assay (ThermoScientific) with BSA as 
standard. 
Thermal denaturation: We used 20 PM of protein for assessing thermal stability of adk variants 
by differential scanning calorimetry (nanoDSC, TA instruments). The scans were carried out 
from 10 to 90 °C at a scan rate of 60 °C/hr. The thermodynamic parameters were derived by 
fitting the data to a two-state unfolding model using NanoAnalyze (TA instruments). 
Enzyme activity: Adk catalyzes the following reaction: . We 
measured the activity of Adk in the direction of ADP formation by a continuous assay. The 
reaction mixture contained a fixed concentration of ATP (1000 PM), varying concentration of 
AMP (from 0 to 500 or 1000 PM), 5 mM MgCl2, 65 mM KCl, 350 PM phosphoenolpyruvate 
(PEP), and 300 PM of NADH. The mix was incubated at 25 °C for 5 minutes for equilibration. 
The reaction was initiated by addition of 5 nM Adk (final concentration) and 2 units of 
pyruvate/lactate dehydrogenase mix. The kinetic traces were recorded every 5 s for a total time 
of 2 minutes. The initial rates v0( ) were estimated and plotted against AMP concentrations. As 
observed previously (27, 28), the kinetic data for varying AMP exhibited a signature of substrate 
inhibition and we modeled it assuming uncompetitive mode of inhibition as follows: 
 v
0
=
k
cat
E
0
éë ùû AMPéë ùû
K
M
+ AMPéë ùû 1+
AMPéë ùû
K
I
æ
èç
ö
ø÷
  (4) 
where K
I
 is the AMP inhibition constant, K
M
 is Michaelis constant for AMP, and E
0
 is the 
concentration of Adk used in the assay. In few cases where inhibition was not apparent, the data 
exhibited hyperbolic pattern. Such traces did not fit well to equation (4) which was exemplified 
by large errors in K
I
 compared to its mean fitted value. These cases were fitted by regular 
Michaelis-Menten equation: 
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 v
0
=
k
cat
E
0
éë ùû AMPéë ùû
K
M
+ AMPéë ùû
  (5) 
Generation of mutant strains: We generated the WT and mutant adk strains of E. coli MG1655 as 
described previously (23, 53). In short, adk variants were cloned in pKD13 having following 
cassette: htpG – REPt44 – CamR – adk – REPt45 – KanR – hemH. As indicated, 
chloramphenicol- and kanamycin-resistance genes are placed on either side of the adk gene, and 
long homology segments were added from upsteam and downstream genes. We amplified the 
whole cassette with ~800 bp of homology-segments, and electroporated in competent BW25113 
cells in which O-red system was already induced. The cells were recovered in 1 ml terrific broth 
for overnight at room temperature and eventually spread on LB-agar plates containing 34 Pg/ml 
chloramphenicol and 50 Pg/ml kanamycin. The colonies were sequenced for correct mutations. 
The mutant adk segments were subsequently transferred to E. coli MG1655 by P1 transduction, 
selected on LB-agar plates with both antibiotics as mentioned above, and the mutations were 
confirmed by sequencing. 
Growth curve measurements and media conditions: The Adk strains were grown for 20 h at 
30 °C from single colonies in M9 media (1× M9 salts, 1 mM MgSO4, 0.2 % glucose). These 
primary cultures were normalized to a final OD600 of 0.01 in fresh M9 media and the growth 
curves were monitored from three colonies in triplicates using Bioscreen C at 37 °C with data 
acquisition at every 15 min. For experiments with AMP, primary cultures were grown as 
mentioned above, and the secondary cultures were grown in M9 media with desired 
concentration of AMP from time 0. 
We derived the growth parameters by fitting ln(OD) versus time plot (with OD
600
t 0.02) with 
the following four-parameter Gompertz function as described previously (23): 
 ln OD( ) = ln OD0( ) + ln K( )exp exp  t  Ob
æ
èç
ö
ø÷
é
ë
ê
ù
û
ú   (6) 
where K is the fold-increase over initial population at saturation, the maximum growth rate is 
P = ln K( ) b ×exp 1( )( ), and the lag time O  is the time taken to achieve the maximum growth 
rate. The error in parameters from replicates was found to be between 2-3% on an average, and it 
did not improve significantly upon increase in number of replicates. 
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Intracellular protein abundance: The WT and mutant strains in MG1655 were initially grown at 
30 °C for 20 h in M9 medium. These primary cultures were normalized to OD600 of 0.01 in fresh 
M9 media and grown for 5 hours at 37 °C. The cells were harvested and subsequently lysed with 
1× BugBuster (Novagen) and 25 U/ml of Benzonase. The cell lysate was divided in two parts: 
one was used to estimate the total amount of proteins, and the other was for the specific fraction 
of Adk. The total amount of proteins in cell lysate was estimated by BCA assay (ThermoFisher). 
We used SDS-PAGE followed by western blot for estimating the intracellular abundance of Adk. 
The Adk bands were detected using anti-Adk polyclonal antibodies custom-raised in rabbit 
(Pacific Immunology). The band intensities on western blot were quantitated using ImageJ and 
were further normalized by the total protein abundance in that lysate (estimated as mentioned 
above). We used three colonies to estimate the intracellular abundance of Adk variants. 
Intracellular metabolite levels: The primary cultures of Adk variants were grown in M9 medium 
as discussed above. The cultures were normalized to OD600 of 0.01 in fresh M9 and grown at 
37 °C for 5 h for exponential phase, and for 12 and 20 h for early and late stationary phase, 
respectively. In case of samples with AMP, the primary cultures were diluted in M9 with 
400 PM of AMP and grown at 37 °C for ~8 h. The culture volumes corresponding to 
~3×9 cells (assuming OD600 of 1 | 8×8 cells/ml) of Adk strains were mixed with 
~5×8 cells of WT grown in M9 containing uniformly 13C-labeled glucose (Cambridge Isotope 
Laboratories, Inc). The labeled culture was used to correct for variability introduced at the 
sample processing stage. The mixed cells were harvested, and the dry pellet weight was 
recorded. Subsequently the metabolites were extracted in 80:20 methanol:water and detected by 
LC-MS as described previously (54). 
The 13C-labeled metabolites were detected using 5 ppm accuracy window around their predicted 
monoisotopic m/z value and retention time. The retention time for the labeled metabolites was 
same as that for the unlabeled metabolites. For correction, we used approximately 16-18 labeled 
metabolites that were common in all the samples. The log of peak area for the labeled 
metabolites was linearly regressed against data from the first colony of WT (arbitrary choice of 
reference) and the regression parameters (slope and intercept) were used to correct the unlabeled 
peak areas. 
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Figure Legends 
Fig 1: Protein stability modulates substrate inhibition by AMP. (A) Crystal structure of 
Adenylate Kinase from E. coli (PDB ID 4ake). The core domain is colored in green, while the 
LID and NMP domains are shown in gray. The Cα atoms of active-site residues are shown in 
pink, and the blue spheres represent the 7 positions which were mutated in this study. Q16 is 
within 4Å of active site and is shown in a red sphere. (B) Representative enzyme activity curves 
of WT, destabilized mutant V106W and a stabilized triple mutant M21A + V169E + L209I as a 
function of varying AMP concentrations. While WT shows moderate drop in velocity of the 
reaction at high AMP concentration, it becomes much more pronounced for the triple mutant, 
resulting in stronger K
I
 (Table 1). Data for both WT and the triple mutant were fitted to 
equation (1) to derive activity parameters and are shown as solid lines. Destabilized mutant 
V106W does not show detectable inhibition in the range of AMP concentration studied, and 
hence was fitted with the conventional Michaelis-Menten equation (also see Methods). (C) 
Inhibition constant K
I( )  derived using equation (1) shows trade-off with stability. WT Adk is 
shown in green, while L82V is shown in light blue. Pearson correlation was calculated between 
mT'  and ( )log IK . The correlation values with and without L82V are r = −0.67, p = 1.1e−3, and 
r = −0.80, p = 3.3e−5, respectively. Error bars in (B) and (C) are SEM of at least three repeats. 
Fig 2: Correlation of activity parameters with protein stability. (A) k
cat
K
M
 correlates 
positively with stability. WT is shown in green, and L82V in light blue. In pink are shown 
proteins that contain mutations at position Q16, which is very close to the active-site (CD is < 4 Å 
of active site residues). Q16 mutants were not considered while calculating correlation 
coefficient. (B) K
I
 of mutant proteins positively correlates with K
M
 of AMP, implying that 
mutants that bind strongly to AMP also exhibit stronger AMP inhibition. Pearson correlation was 
calculated using log values of both K
M
 and K
I
. (C) K
I
 negatively correlates with k
cat
K
M
 of 
mutant proteins. This correlation is primarily driven by positive correlation between K
M
 and K
I
. Pearson correlations calculated using log values of K
I
 are r = −0.65, p = 2.8e−3, and r = −0.55, 
p = 0.03 without and with mutant L82V (shown in light blue). 
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Fig 3: Fitness effects in the presence of excess AMP. Growth rate (A) and lag times (B) of 
mutant Adk strains in the absence (0 PM) and presence of different concentrations of AMP (50-
400 PM) in growth media. Except for L82F, most mutants with weaker inhibition than WT show 
minimal changes in growth rate and lag times upon exposure to AMP. On the other hand, 
mutants with stronger K
I
 than WT generally exhibit considerable drop in fitness with increasing 
concentrations of AMP. The stability of the mutants is shown in (C). (D) Change in growth rate 
of Adk mutants in the presence of external AMP relative to zero AMP is plotted against change 
in flux ( )0AMPV V  in those conditions. The flux is calculated using equation (3). (E) Similar plot 
as in (D) for change in lag times. In both (C) and (D), the Spearman correlation coefficient is 
highly significant. 
Fig 4: Mutants with stronger inhibition accumulate all three adenylate species in the 
presence of excess AMP during exponential phase. In the absence of AMP, intracellular levels 
of ATP, ADP, AMP are similar in WT and mutants V106W, L107I+V169E and L82V. 
However, in the presence of 400 PM external AMP, mutants L107I+V169E and L82V which 
show strong AMP inhibition, show considerable accumulation of all three adenylate species. In 
comparison, mutant V106W which shows no AMP inhibition, does not show measurable 
accumulation. WT behaves similar to V106W. In all cases however, cells convert AMP (a 
putative starvation signal) to IMP, which leads to increase in intracellular IMP levels. 
Fig 5: Fitness effects under physiological conditions. (A) The metabolites were measured in 
the absence of any additional AMP at 5, 12, and 20 h of growth, timepoints that correspond to 
the exponential phase, and early- and late-stationary phase, respectively. Levels of adenylate 
metabolites drop drastically in stationary phase compared to that in the exponential phase. The 
overall trend of drop is similar in both WT and L82V. ATP for WT at 12 h was not detected 
faithfully. (B) Levels of all three adenylate metabolites is higher in L82V relative to WT during 
stationary phase. (C) Change in lag times of mutant Adk strains relative to WT at zero external 
AMP is plotted against change in flux ( )mut WTV V  considering > @WTAMP  as 70 PM (25% of that 
in exponential phase, 280 PM) and > @mutAMP  as 96 PM (1.38-fold over WT levels). The 
Spearman correlation coefficient is significant U = −0.54, p = 2.8e−2. (D) Modeling of AMP 
regimes for WT and mutants: Intracellular concentration of AMP in WT at stationary phase was 
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assumed to vary from 25 PM to 100 PM at an interval of 1 PM. At each concentration of WT, 
the ratio of > @ > @mut WTAMP AMP  was varied from 0.4 to 4.0 at an interval of 0.01, and change in 
flux ( )mut WTV V  was calculated as in (C). We assumed all mutants contain same amount of AMP 
in the stationary phase. The plot shows a contour map of the spearman correlation coefficients 
between change in lag times of Adk variants at zero external AMP and ( )mut WTV V , calculated 
for different pairs of > @WTAMP and > @mutAMP . Red region corresponds to the highest values of 
correlation while blue represents lowest. The dashed yellow line represents the contour line of 
0.05p = , above which the correlation is significant, i.e., 0.05p  . The blue dashed lines 
represent AMP concentrations used in panel (C). This plot shows that flux through mutant Adk 
can describe the variation in lag times significantly only when mutants have higher concentration 
of AMP in stationary phase relative to WT. Our experimental data with mutant L82V is in 
agreement with this finding. 
Fig 6: Schematic fitness landscape depicting purifying selection at high stability. A 
schematic landscape depicting a fitness cost at high protein stability primarily arising through 
substrate inhibition. In Adk, increased stability of proteins results in increased substrate 
inhibition, which in turn reduces flux through the enzyme, and eventually causes a drop in 
fitness. Hence, substrate inhibition in Adk results in a bell-shaped fitness landscape along the 
stability axis signifying the purifying selection at high stability. The arrows on all axes are 
pointed to the increasing direction. 
Table 1: Biophysical properties of Adk mutants 
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Table 1: Biophysical propeties of Adk mutants
Mutant DTm (°C)a
kcat (µM of 
ADP/min/nM of 
Adk)b KM (µM of AMP)b KI (µM of AMP)b,c
distance from 
AP5A (Å)
V106H -11.7 93.2 (2.1) 133.6 (9.5) NAd 13.4
V106W -9.9 72.6 (4.6) 195.7 (35.3) NAd 13.4
L082F -5.7 87.3 (6.9) 84.8 (13.7) 2302.0 (738.2) 10.5
A093F -5.5 87.0 (8.6) 91.3 (16.5) 889.1 (209.7) 8.7
V106A -5.2 72.0 (6.5) 58.0 (11.1) 1287.0 (355.5) 13.4
V106L -4.8 106.6 (2.4) 190.5 (12.2) NAd 13.4
A093L -4.3 80.8 (3.4) 119.8 (16.5) NAd 8.7
A093Y -3.7 85.7 (7.9) 97.0 (18.0) 3046.0 (1349.0) 8.7
A093I -3.6 69.0 (5.6) 349.8 (67.8) NAd 8.7
L083I -2.5 105.9 (5.4) 259.1 (34.7) NAd 8.8
WT 0.0 68.6 (3.6) 46.8 (5.2) 930.5 (154.7)
Y182F 0.5 88.1 (7.0) 87.0 (14.0) 2365.0 (766.8) 10.7
L083F 0.6 73.9 (4.5) 94.1 (9.6) 680.2 (106.1) 8.8
E210L 0.7 85.8 (7.3) 115.1 (15.7) 638.1 (132.1) 13.1
L082V 0.8 28.5 (8.3) 36.2 (17.0) 76.6 (33.4) 10.5
V169E 1.8 63.1 (4.0) 83.6 (9.2) 595.9 (92.9) 10.0
L209I 2.6 36.9 (2.0) 32.7 (3.7) 382.9 (45.0) 9.4
M021A 2.8 68.5 (6.4) 48.2 (9.4) 729.5 (166.3) 12.5
V169E + L209I 2.8 71.8 (3.6) 38.5 (4.0) 460.5 (54.2)
L107I 3.2 23.6 (1.4) 22.4 (3.2) 511.7 (77.4) 9.5
M021A + V169E 3.5 60.4 (2.5) 43.3 (3.6) 456.4 (44.3)
L107I + V169E 3.5 97.6 (5.6) 60.6 (6.3) 453.0 (57.6)
M021A + L209I 3.8 55.7 (2.7) 25.5 (2.6) 227.4 (20.7)
M021A + L107I 4.3 72.2 (5.6) 43.2 (6.0) 211.3 (28.1)
M021A + V169E + L209I 4.7 64.0 (2.5) 31.6 (2.5) 228.9 (16.4)
M021A + L107I + V169E 5.2 68.8 (3.7) 37.7 (4.0) 308.6 (32.9)
Q016Y 5.4 4.9 (1.1) 186.3 (118.3) NAd 5.1
Q016F 6.5 10.6 (1.4) 324.2 (101.0) NAd 5.1
Q016F + V169E 7.3 20.6 (3.9) 479.3 (156.5) NAd
Q016F + L107I 8.1 21.9 (2.7) 286.8 (74.2) NAd
Q016F + L107I + V169E 8.5 14.0 (2.8) 241.0 (107.0) NAd
Q016F + M021A 8.7 24.0 (3.4) 491.7 (118.4) NAd
a Tm of WT Adk is 54.9 °C
b numbers in the parenthesis are s.e.m. of minimum 3 repeats
c The kinetic data was fit to uncompetitive model of inhibition (see Methods Eq. 4)
d The kinetic data was fit to standard Michael Menten equation (see Methods Eq. 5)
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Supplementary Figures and Table: 
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 Fig S1: Activity parameters vs stability. Correlation between k
cat
 (A) or K
M
 (B) and protein stability is 
shown. Log values of K
M
 were used for correlation calculations. The WT is shown in green, L82V in light 
blue, whereas all mutants involving mutation at Q16 position are shown in pink circles. The error bars are 
s.e.m. of three measurements. In both panels, Pearson correlations are calculated without considering 
Q16 mutants (red points). 
  
 Fig S2: Pilot experiment to estimate the dynamic range of AMP effect on fitness. A pilot experiment with 
only WT and L82V, the most inhibited mutant in this study, were grown in M9 media containing various 
amounts of AMP. Relative lag times increase substantially up to 400 PM of AMP, following which the 
changes are smaller. The error bars are s.e.m. from three colonies. 
  
 Fig S3: Schematic of possible effects of stabilization on enzyme mechanics. The schema depicts an energy 
landscape during catalysis. WT scheme is shown in black lines, whereas that of a stabilizing version is in 
red. EO and EC are the ‘open’ and ‘closed’ states of the enzyme. The more stable enzyme may 
preferentially stabilize the ligand-bound closed state more than the unbound open state, which will be 
reflected in stronger DK  and hence stronger MK . Such preference may also result in a high activation 
barrier  #ATP ATPAMP AMPEC ECo , which results in reduced catk . 
  
 Fig S4: Ap5A binding by ITC. Binding of a bidentate inhibitor Ap5A was measured by ITC to WT, L82V, and 
M21A+L107I. The concentration of protein used in the cell was 96.7 PM of WT, and 24.1 PM each of the 
two mutants. 1 mM of the inhibitor was used in syringe for WT and M21A+L107I, whereas 200 PM was 
used for L82V titrations. The binding measurement was done at 25 °C. 
 
Table S1: Growth parameters of Adk strains
mean SEM mean SEM
V106W 0.0087 0.0001 240.4 6.1
Q016F 0.0107 0.0001 248.0 1.0
Q016F + V169E 0.0099 0.0001 259.3 1.3
V106H 0.0126 0.0001 189.7 2.4
L083I 0.0091 0.0001 240.9 4.2
A093L 0.0091 0.0001 218.4 10.2
A093I 0.0093 0.0002 243.3 2.4
L082F 0.0132 0.0001 233.2 3.5
WT 0.0133 0.0003 239.1 4.1
M021A 0.0130 0.0004 241.2 4.3
L083F 0.0112 0.0001 235.9 2.8
V169E 0.0130 0.0009 241.0 3.5
L107I 0.0121 0.0007 248.9 4.1
M021A + V169E 0.0143 0.0004 248.7 2.2
L107I + V169E 0.0137 0.0003 234.8 1.9
L209I 0.0102 0.0002 246.3 7.3
M021A + V169E + L209I 0.0099 0.0003 235.8 6.5
L082V 0.0100 0.0001 268.7 6.0
All experiments were done in triplicates with at least three colonies (biological repeats)
Growth rate (min-1) Lag time (min)Mutant
